Isorel

    In Germany and Austria for the last 20 years a new treatment, based on mistletoe extracts: Isorel (Iskador, Vysorel) has been found. The compound is found under 3 forms:
    • Isorel A Viscum album Abietis (fir tree)
    • Isorel M Viscum album Mali (apple tree)
    • Isorel P Viscum album Pini (pine tree)
    The healing properties of mistletoe are known for quite a while, because it has also been tried in the treatment of other diseases, such as epilepsy, or sterility. In 1920, R. Steiner proposed the using of this compound in the fight against cancer, but studies have shown, but studies have been reinitiated with more insistence after 1980.
    The effects of Isorel are the shaping and the stimulation of the immune system and the toxic citostatic level of tumors. These effects are not found together in any other anti- tumors products, moreover the suppression of the immune system caused by citostatics is well- known.
    Another advantage is represented by the lack of adverse reactions.
    The compound is unadvisable in the following circumstances:
    - A great sensibility to mistletoe compounds, being advisable to hypo sensitization the organism to prevent reactions;
    - Hyperthyroid, pregnancy and during lactation period.
    Direct toxicity of citostatics proved in experimental studies is probably based on the Isorel’ s property to decrease in specially the G. A. G. synthesis and the acizi proteoglicani, substances that appear in tumor tissues.
    Modulating the immune system: seems to be a result of the 3 mistletoe components: mistletoe toxins (proteins who release an active factor of macrophage), polizaharide and most of all lectine (glycoprotein) considered to be the central elements of mistletoe extract. These last ones, aside the toxic citostatic direct effect, step into the intercellular transmission of information and the release of cytokines.
    The range of use for Isorel reaches most types of cancer, but recent statistics show a wider range of use for breast cancer (60 %), ovary cancer (15 %) and pulmonary cancer (18 %).
    In the case of breast cancer, in 80 % of the cases, a significant growth of survival has been noticed, even if it has been or not accompanied by radio or chemo therapy.
    In the case of pulmonary cancer, better results have been obtained that in the case of typical cancer treatments, and in some cases, even the total remission of tumors considered inoperable. A study made by researchers from Cluj has shown the protective role of Isorel in the appearance of pulmonary cancer.
    The surprising results have been obtained with SNC tumors even if initially it was thought that Isorel can not cross barrier hemato- encephalitic.
    Total remissions have been reported after i.v. treatment with Isorel in the case of larynx tumors and the most severe forms of bone cancer. Isorel can be valid hope for cases placed beyond surgical or therapeutic means or with no good answer to chemo or radio therapy and for patients that refuse surgery and conventional treatment.
    Aside the anti- tumors and modulating role for the immune system, Isorel has other benefic effects for the cancer patient:
    - Better appetite for food and sleep
    - It lowers the intensity of pain, reducing the painkiller number
    - It improves the general state
    The 10 day preparing treatment and I.V. therapy with Isorel are presented below:

Day 110 g ascorbic acid in 250 ml NaCl 0.9%1 vial of Rhodizonsaure, 1 vial of Mucokehl D5+, 1 vial of Citrokehl
Day 210 selenium vials in 250 ml NaCl 0.9%1 vial of Carbonylgruppen, 1 vial of Parabenzochinon, 1 vial of Nigersan
Day 310 g ascorbic acid in 250 ml NaCl 0.9%1 vial of Rhodizonsaure, 1 vial of Mucokehl D5+, 1 vial of Citrokehl
Day 410 selenium vials in 250 ml NaCl 0.9%1 vial of Carbonylgruppen, 1 vial of Parabenzochinon, 1 vial of Nigersan
Day 510 g ascorbic acid in 250 ml NaCl 0.9%1 vial of Rhodizonsaure, 1 vial of Mucokehl D5+, 1 vial of Citrokehl
Day 610 selenium vials in 250 ml NaCl 0.9%1 vial of Carbonylgruppen, 1 vial of Parabenzochinon, 1 vial of Nigersan
Day 710 g ascorbic acid in 250 ml NaCl 0.9%1 vial of Rhodizonsaure, 1 vial of Mucokehl D5+, 1 vial of Citrokehl
Day 810 selenium vials in 250 ml NaCl 0.9%1 vial of Carbonylgruppen, 1 vial of Parabenzochinon, 1 vial of Nigersan
Day 910 g ascorbic acid in 250 ml NaCl 0.9%1 vial of Rhodizonsaure, 1 vial of Mucokehl D5+, 1 vial of Citrokehl
Day 1010 selenium vials in 250 ml NaCl 0.9%1 vial of Carbonylgruppen, 1 vial of Parabenzochinon, 1 vial of Nigersan

    Hypodermic administration is recommended and also the beginning of treatment by testing an eventual hyper sensibility , administrating diluted doses of Isorel of 1, 6, 12 , 24 or 36 mg/ml or successive diluted portions of 0,1- 0,9 ml of Isorel in the amount of 60 mg/ml of NaCl solution.
    Usually 1-3 vials of Isorel consisting of 60mg/ml daily or 3-9 vials of Isorel, consisting of 60 mg/ml weekly at doctor’s orders at the second or third level of disease.
    The daily maximal dose is of 5 vials of Isorel consisting of 60mg/ml. To prevent backsliding and terminal states after the surgery treatment and radio therapy 9-12 vials of Isorel consisting of 60mg/ml weekly in the third or forth state.
    In the treating of pre cancer states the administration of 1 vial of Isorel is recommended 3 times a week, vial consisting of 60mg/l.
    Second table- I.V. Isorel treatment

MondayTuesdayWednesdayThursdayFridaySaturdaySunday
First week2-4-6--
Second week8-10-12--
Third week14-16-18--
Fourth week20-18-16--
Fifth week14-12-10--
Sixth week12-6-6--
Seventh week18-20-18--

    The vials are administrated in 250 ml of 0.9 NaCl during 90 to 120 minutes.
    The cycle is repeated until stabilization is reached.
    To prevent backsliding and the critical state of the disease after the surgery and radio therapy, 9-12 vials of Isorel can be administered, consisting of 60mg/ml weekly in the third and fourth state.
    In treating pre cancer states the administrating of 1 vial of Isorel 3 times a week is recommended, consisting of 60mg/ml.
    In the Surgery Clinic II in Targu- Mures a number of 312 patients have been treated with Isorel in the last 6 years, having different forms of the disease, surgeries and treatment with the intention to exterminate. All patients have had histopathological confirmation. Some of these patients have followed natural food diets, tea treatments. We have forbidden the use of the possibilities offered by alternative medicine or the follow of classic oncology treatments like chemotherapy.
    We can present a fair statistic:
    - some patients followed surgical treatment + Isorel + natural diets
    - some patients followed surgical treatment + Isorel
    - some patients followed surgical treatment + Isorel + homeopathic treatment
    - some patients followed surgical treatment + oncology treatment (chemo and cobalt therapy) + Isorel after the oncology treatment finished
    For these reason we can not attribute the long survival rate of some patients only to Isorel treatment. What we have noticed in the biggest majority of theses cases is a general, unhoped-for, better biological state and a resistance to current infections (like flue), superior to the one their friends have, which is very easily noticeable by the family.
    Composition
    One vial of 1ml contains watery extract of Viscum album ssp. Abietis, planta tota 991.54 mg in isotonic NaCl solution.
    Pharmaceutical form
    Injectable solution for hypodermic, intramuscular or I.V. use
    Therapeutically indications
    Complementary therapy at malign tumors chemotherapy and radiotherapy for post- surgery and post- radiotherapy backsliding preventing and for precancerous states prophylaxis. Peri-surgery modulation of the immune system and latent immune deficiency.
    Doses and administration interval
    1-3 Isorel vials/ day of 60mg/ml, three times a week (ex: Mo, Wed, Fry) - tumors in I/II degree. For preventing backsliding after surgical interventions and radiotherapy- 3-5 Isorel vials of 60mg/ml, three times a week- tumors in III/IV degree. For peri-surgery modulation of the immune system, the duration of the treatment is: 2 weeks before and 2 after the surgery. The dose is 6 Isorel vials of 60mg/ml a week, graduated in three administrations a week.